Hexahydrocannabinol and closely related semi-synthetic cannabinoids: A comprehensive review
- PMID: 37269160
- DOI: 10.1002/dta.3519
Hexahydrocannabinol and closely related semi-synthetic cannabinoids: A comprehensive review
Abstract
Since the early 2000s, there has been a turmoil on the global illicit cannabinoid market. Parallel to legislative changes in some jurisdictions regarding herbal cannabis, unregulated and cheap synthetic cannabinoids with astonishing structural diversity have emerged. Recently, semi-synthetic cannabinoids manufactured from hemp extracts by simple chemical transformations have also appeared as recreational drugs. The burst of these semi-synthetic cannabinoids into the market was sparked by legislative changes in the United States, where cultivation of industrial hemp restarted. By now, hemp-derived cannabidiol (CBD), initially a blockbuster product on its own, became a "precursor" to semi-synthetic cannabinoids such as hexahydrocannabinol (HHC), which appeared on the drug market in 2021. The synthesis and cannabimimetic activity of HHC were first reported eight decades ago in quest for the psychoactive principles of marijuana and hashish. Current large-scale manufacture of HHC is based on hemp-derived CBD extract, which is converted first by cyclization into a Δ8 /Δ9 -THC mixture, followed by catalytic hydrogenation to afford a mixture of (9R)-HHC and (9S)-HHC epimers. Preclinical studies indicate that (9R)-HHC has THC-like pharmacological properties. The animal metabolism of HHC is partially clarified. The human pharmacology including metabolism of HHC is yet to be investigated, and (immuno)analytical methods for the rapid detection of HHC or its metabolites in urine are lacking. Herein, the legal background for the revitalization of hemp cultivation, and available information on the chemistry, analysis, and pharmacology of HHC and related analogs, including HHC acetate (HHC-O) is reviewed.
Keywords: HHC; analysis; hexahydrocannabinol; pharmacology; synthesis.
© 2023 John Wiley & Sons Ltd.
Similar articles
-
Hexahydrocannabinol on the Light Cannabis Market: The Latest "New" Entry.Cannabis Cannabinoid Res. 2024 Apr;9(2):622-628. doi: 10.1089/can.2022.0253. Epub 2022 Nov 23. Cannabis Cannabinoid Res. 2024. PMID: 36445181
-
Synthesis and pharmacological activity of the epimers of hexahydrocannabinol (HHC).Sci Rep. 2023 Jul 8;13(1):11061. doi: 10.1038/s41598-023-38188-5. Sci Rep. 2023. PMID: 37422571 Free PMC article.
-
Analytical toxicology of the semi-synthetic cannabinoid hexahydrocannabinol studied in human samples, pooled human liver S9 fraction, rat samples and drug products using HPLC-HRMS-MS.J Anal Toxicol. 2023 Dec 12;47(9):818-825. doi: 10.1093/jat/bkad079. J Anal Toxicol. 2023. PMID: 37864499
-
The Dark Side of Cannabidiol: The Unanticipated Social and Clinical Implications of Synthetic Δ8-THC.Cannabis Cannabinoid Res. 2023 Apr;8(2):270-282. doi: 10.1089/can.2022.0126. Epub 2022 Oct 19. Cannabis Cannabinoid Res. 2023. PMID: 36264171 Free PMC article. Review.
-
Saturated Cannabinoids: Update on Synthesis Strategies and Biological Studies of These Emerging Cannabinoid Analogs.Molecules. 2023 Sep 4;28(17):6434. doi: 10.3390/molecules28176434. Molecules. 2023. PMID: 37687263 Free PMC article. Review.
Cited by
-
Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays-and how this matters for the harm potential of seized drugs.Arch Toxicol. 2024 Aug;98(8):2619-2630. doi: 10.1007/s00204-024-03769-4. Epub 2024 May 12. Arch Toxicol. 2024. PMID: 38735004
-
An emerging trend in Novel Psychoactive Substances (NPSs): designer THC.J Cannabis Res. 2024 May 3;6(1):21. doi: 10.1186/s42238-024-00226-y. J Cannabis Res. 2024. PMID: 38702834 Free PMC article. Review.
-
Disposition of Hexahydrocannabinol Epimers and Their Metabolites in Biological Matrices following a Single Administration of Smoked Hexahydrocannabinol: A Preliminary Study.Pharmaceuticals (Basel). 2024 Feb 15;17(2):249. doi: 10.3390/ph17020249. Pharmaceuticals (Basel). 2024. PMID: 38399464 Free PMC article.
-
Cannabidiol-Derived Cannabinoids: The Unregulated Designer Drug Market Following the 2018 Farm Bill.Med Cannabis Cannabinoids. 2024 Feb 13;7(1):10-18. doi: 10.1159/000536339. eCollection 2024 Jan-Dec. Med Cannabis Cannabinoids. 2024. PMID: 38352661 Free PMC article. Review.
-
Molecular Insights of New Psychoactive Substances (NPS) 2.0.Int J Mol Sci. 2023 Dec 14;24(24):17492. doi: 10.3390/ijms242417492. Int J Mol Sci. 2023. PMID: 38139320 Free PMC article.
References
REFERENCES
-
- Small E. Cannabis: A Complete Guide. CRC Press; 2017.
-
- United Nations Conference on Trade and Development. Commodities at a Glance: Special Issue on Industrial Hemp. UNCTAD/DITC/COM/2022/1. United Nations; 2022. Accessed April 14, 2023. https://unctad.org/system/files/official-document/ditccom2022d1_en.pdf
-
- Single Convention on Narcotic Drugs, 1961. Accessed April 14, 2023. https://treaties.un.org/doc/Publication/UNTS/Volume%20520/volume-520-I-7...
-
- United Nations Office on Drugs and Crime. World Drug Report 2022. United Nations; 2022.
-
- European Monitoring Centre for Drugs and Drug Addiction. 2009. Accessed April 14, 2023. Understanding the ‘Spice’ phenomenon. Office for Official Publications of the European Communities, Luxembourg. https://www.emcdda.europa.eu/publications/thematic-papers/understanding-...
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources